Compounding Priorities
NASEM’s cBHT Recommendations
Why we need to use the evidence
Animal Compounding
Working for more reasonable FDA guidance
The FDA’s MOU
Bad for states, bad for compounders, bad for patients
Tricare Clawbacks
Fighting the Tricare/ESI Recoupment
